202 related articles for article (PubMed ID: 10509166)
21. Arsenic trioxide in patients with adenocarcinoma of the pancreas refractory to gemcitabine: a phase II trial of the University of Chicago Phase II Consortium.
Kindler HL; Aklilu M; Nattam S; Vokes EE
Am J Clin Oncol; 2008 Dec; 31(6):553-6. PubMed ID: 19060586
[TBL] [Abstract][Full Text] [Related]
22. A phase I study of gemcitabine given via intrahepatic pump for primary or metastatic hepatic malignancies.
Tse AN; Wu N; Patel D; Haviland D; Kemeny N
Cancer Chemother Pharmacol; 2009 Oct; 64(5):935-44. PubMed ID: 19221752
[TBL] [Abstract][Full Text] [Related]
23. Gemcitabine doublets in advanced pancreatic cancer: should we move on?
Rocha Lima CM; Flores AM
J Clin Oncol; 2006 Jan; 24(3):327-9. PubMed ID: 16344312
[No Abstract] [Full Text] [Related]
24. [A case of pancreatic cancer complicated by gemcitabine-induced peripheral edema].
Shitara K; Ishiguro A; Munakata M; Sakata Y; Hirata N; Yabu K; Wada R
Gan To Kagaku Ryoho; 2005 Nov; 32(12):1981-4. PubMed ID: 16282740
[TBL] [Abstract][Full Text] [Related]
25. Gemcitabine-induced myositis in a diabetes mellitus patient on hemodialysis.
Chun JY; Lee JM; Ahn DW; Chai JW; Kim YA; Shin K
Korean J Intern Med; 2017 Sep; 32(5):930-932. PubMed ID: 26922072
[No Abstract] [Full Text] [Related]
26. Randomized phase II comparison of dose-intense gemcitabine: thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma.
Tempero M; Plunkett W; Ruiz Van Haperen V; Hainsworth J; Hochster H; Lenzi R; Abbruzzese J
J Clin Oncol; 2003 Sep; 21(18):3402-8. PubMed ID: 12885837
[TBL] [Abstract][Full Text] [Related]
27. [Acute respiratory distress syndrome after antineoplastic chemotherapy. Probable role of gemcitabine].
de Lavigerie B; Joasson JM
Presse Med; 2001 May 5-12; 30(17):851-4. PubMed ID: 11402938
[TBL] [Abstract][Full Text] [Related]
28. Features of gemcitabine-related severe pulmonary toxicity: patients with pancreatic or biliary tract cancer.
Tamiya A; Endo M; Shukuya T; Igawa S; Tsuya A; Nakamura Y; Murakami H; Takahashi T; Boku N; Yamamoto N
Pancreas; 2009 Oct; 38(7):838-40. PubMed ID: 19893461
[No Abstract] [Full Text] [Related]
29. Gemcitabine induced myositis in patients with pancreatic cancer: case reports and topic review.
Pentsova E; Liu A; Rosenblum M; O'Reilly E; Chen X; Hormigo A
J Neurooncol; 2012 Jan; 106(1):15-21. PubMed ID: 21811892
[TBL] [Abstract][Full Text] [Related]
30. [A case of advanced pancreatic cancer showing remarkable response to gemcitabine treatment].
Masaki T; Ohkawa S; Hirokawa S; Miyakawa K; Tamai S; Tarao K
Gan To Kagaku Ryoho; 2003 Sep; 30(9):1333-6. PubMed ID: 14518416
[TBL] [Abstract][Full Text] [Related]
31. Gemcitabine-induced respiratory failure associated with elevated erythrocyte sedimentation rate (ESR).
Davidoff S; Shah RD; Arunabh T
Respir Med; 2006 Apr; 100(4):760-3. PubMed ID: 16199150
[TBL] [Abstract][Full Text] [Related]
32. First case report associating gemcitabine with hypersensitivity reaction in a patient with pancreatic cancer.
Saif MW; Chakerian P; Kaley K; Lamb L
JOP; 2010 May; 11(3):273-4. PubMed ID: 20442527
[No Abstract] [Full Text] [Related]
33. Gemcitabine-induced severe extremity edema with muscle contractures and subsequent prevention with prednisone.
Geffen DB; Horowitz J
Isr Med Assoc J; 2000 Jul; 2(7):552-3. PubMed ID: 10979335
[No Abstract] [Full Text] [Related]
34. Diffuse alveolar damage in a patient treated with gemcitabine.
Marruchella A; Fiorenzano G; Merizzi A; Rossi G; Chiodera PL
Eur Respir J; 1998 Feb; 11(2):504-6. PubMed ID: 9551762
[TBL] [Abstract][Full Text] [Related]
35. Severe pulmonary toxicity in a patient treated with gemcitabine.
Rosado MF; Kett DH; Schein RM; Baraona FJ; Sridhar KS
Am J Clin Oncol; 2002 Feb; 25(1):31-3. PubMed ID: 11823691
[TBL] [Abstract][Full Text] [Related]
36. A phase I trial of weekly gemcitabine administered as a prolonged infusion in patients with pancreatic cancer and other solid tumors.
Brand R; Capadano M; Tempero M
Invest New Drugs; 1997; 15(4):331-41. PubMed ID: 9547676
[TBL] [Abstract][Full Text] [Related]
37. Fixed-dose-rate gemcitabine infusion in patients with advanced pancreatic or biliary tree adenocarcinoma.
Mané JM; Sancho A; Muñoz A; Rubio I; Fernández R; Carrera S; Fuente N; Ballesteros D; Casas R; Marrodán I; Mielgo X; López-Vivanco G
Tumori; 2010; 96(3):405-10. PubMed ID: 20845800
[TBL] [Abstract][Full Text] [Related]
38. Phase II trial of a 24-hour infusion of gemcitabine in previously untreated patients with advanced pancreatic adenocarcinoma.
Eckel F; Schmelz R; Erdmann J; Mayr M; Lersch C
Cancer Invest; 2003; 21(5):690-4. PubMed ID: 14628426
[TBL] [Abstract][Full Text] [Related]
39. [Severe interstitial pneumonitis related to Gemcitabine].
Sabria-Trias J; Bonnaud F; Sioniac M
Rev Mal Respir; 2002 Oct; 19(5 Pt 1):645-7. PubMed ID: 12473953
[TBL] [Abstract][Full Text] [Related]
40. Gemcitabine-induced pulmonary toxicity in a patient with pancreatic cancer.
Hiraya D; Kagohashi K; Sakamoto N; Kondo T; Satoh H
JOP; 2010 Mar; 11(2):186-8. PubMed ID: 20208333
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
